Increase in work productivity of depressed individuals with improvement in depressive symptom severity

American Journal of Psychiatry

Volumn 170, Issue 6, 2013, Pages 633-641

  Trivedi, Madhukar H ^a   Morris, David W ^a   Wisniewski, Stephen R ^a   Lesser, Ira ^a   Nierenberg, Andrew A ^a   Daly, Ella ^a   Kurian, Benji T ^a   Gaynes, Bradley N ^a   Balasubramani, G K ^a   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGED; ANXIETY; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SUBSTITUTION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; HUMAN; MAJOR DEPRESSION; MELANCHOLIA; MOOD; ONSET AGE; OUTPATIENT; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; RECURRENT DEPRESSION; REMISSION; SCORING SYSTEM; SUICIDE ATTEMPT; TREATMENT OUTCOME; WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT SCALE; ADOLESCENT; CLINICAL TRIAL; DELAYED RELEASE FORMULATION; DRUG COMBINATION; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SEVERITY OF ILLNESS INDEX; WORK;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; CITALOPRAM; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DEPRESSION; DRUG THERAPY, COMBINATION; EFFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WORK; YOUNG ADULT;

EID: 84882248167     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2012.12020250     Document Type: Article

References (39)

1. Murray C, Lopez A: Global Health Statistics: A Compendium of Incidence, Prevalence, and Mortality Estimates for Over 200 Conditions. Cambridge, Harvard School of Public Health, 1996
2. Murray CJL, Lopez AD (eds): The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, vol Cambridge, Mass, Harvard School of Public Health, on behalf of the World Health Organization and the World Bank, 1996
3. Stewart WF, Ricci JA, Chee E, Morganstein D: Lost productive work time costs from health conditions in the United States: results from the American Productivity Audit. J Occup Environ Med 2003; 45: 1234-1246
4. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D: Cost of lost productive work time among US workers with depression. JAMA 2003; 289: 3135-3144
5. Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RMA, Jin R, Merikangas KR, Simon GE, Wang PS: Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry 2006; 163: 1561-1568
6. Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D: Job performance deficits due to depression. Am J Psychiatry 2006; 163: 1569-1576
7. Druss BG, Schlesinger M, Allen HM Jr: Depressive symptoms, satisfaction with health care, and 2-year work outcomes in an employed population. Am J Psychiatry 2001; 158: 731-734
8. Veiel HOF: A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 1997; 19: 587-603
9. Elliott R: Executive functions and their disorders. Br Med Bull 2003; 65: 49-59
10. Silva H, Larach V: Treatment and recovery rate in depression: a critical analysis. World J Biol Psychiatry 2000; 1: 119-123
11. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ: Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am 2003; 26: 457-494
12. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G; STAR*D Investigators Group: Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials 2004; 25: 119-142
13. Kobak KA, Taylor LH, Dottl SL, Greist JH, Jefferson JW, Burroughs D, Mantle JM, Katzelnick DJ, Norton R, Henk HJ, Serlin RC: A computer-administered telephone interview to identify mental disorders. JAMA 1997; 278: 905-910
14. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62
15. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296
16. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), Clinician Rating (QIDS-C), and Self- Report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583
17. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004; 34: 73-82
18. Rush AJ, Bernstein IH, Trivedi MH, Carmody TJ, Wisniewski S, Mundt JC, Shores-Wilson K, Biggs MM, Woo A, Nierenberg AA, Fava M: An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a Sequenced Treatment Alternatives to Relieve Depression trial report. Biol Psychiatry 2006; 59: 493-501
19. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH: The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26: 477-486
20. Linn BS, Linn MW, Gurel L: Cumulative Illness Rating Scale. J Am Geriatr Soc 1968; 16: 622-626
21. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF 3rd: Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41: 237-248
22. Miller M, Tower A: A Manual of Guidelines for Scoring the Cumulative Illness Rating Scale for Geriatrics (CIRS-G). Pittsburgh, University of Pittsburgh, 1991
23. Zimmerman M, Mattia JI: A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001; 58: 787-794
24. Zimmerman M, Mattia JI: The Psychiatric Diagnostic Screening Questionnaire: development, reliability, and validity. Compr Psychiatry 2001; 42: 175-189
25. Reilly MC, Zbrozek AS, Dukes EM: The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353-365
26. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care 1992; 30: 473-483
27. Chirban J, Jacobs R, Warren J, Prakash E, Sodomsky M, Clarke J: The 36-item Short-Form Health Survey (SF-36) and the Work Productivity and Activity Impairment (WPAI) questionnaire in panic disorder. Dis Manag Health Outcomes 1997; 1: 154-164
28. Mundt JC, Marks IM, Shear MK, Greist JH: The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002; 180: 461-464
29. Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29: 321-326
30. Ware JE Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233
31. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project: International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-1178
32. Mintz J, Mintz LI, Arruda MJ, Hwang SS: Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761-768
33. Simon GE, Chisholm D, Treglia M, Bushnell D; LIDO Group: Course of depression, health services costs, and work productivity in an international primary care study. Gen Hosp Psychiatry 2002; 24: 328-335
34. Zhang ML, Rost KM, Fortney JC: Earnings changes for depressed individuals treated by mental health specialists. Am J Psychiatry 1999; 156: 108-114
35. Berndt ER, Finkelstein SN, Greenberg PE, Howland RH, Keith A, Rush AJ, Russell J, Keller MB: Workplace performance effects from chronic depression and its treatment. J Health Econ 1998; 17: 511-535
36. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR, Fourth Edition (Text Revision). Washington, DC, American Psychiatric Association, 2000
37. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S: Well-being therapy: a novel psychotherapeutic approach for residual symptoms of affective disorders. Psychol Med 1998; 28: 475-480
38. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores- Wilson K, Biggs MM, Balasubramani GK, Fava M; STAR*D Study Team: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40
39. Trivedi MH, Rush AJ, Gaynes BN, Stewart JW, Wisniewski SR, Warden D, Ritz L, Luther JF, Stegman D, Deveaugh-Geiss J, Howland R: Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurementbased care. Neuropsychopharmacology 2007; 32: 2479-2489